de Muijnck Cansu, van Gorkom Yoren, van Duijvenvoorde Maurice, Eghtesadi Mina, Dekker-Ensink Geeske, Bhairosingh Shadhvi S, Affinito Alessandra, Kuppen Peter J K, Vahrmeijer Alexander L, Sier Cornelis F M
Department of Surgery, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.
Percuros BV, 2333 CL Leiden, The Netherlands.
Pharmaceuticals (Basel). 2020 Jul 30;13(8):172. doi: 10.3390/ph13080172.
Targeted image-guided surgery is based on the detection of tumor cells after administration of a radio-active or fluorescent tracer. Hence, enhanced binding of a tracer to tumor tissue compared to healthy tissue is crucial. Various tumor antigens have been evaluated as possible targets for image-guided surgery of breast cancer, with mixed results.
In this study we have evaluated tyrosine kinase receptor EphB4, a member from the Eph tyrosine kinase receptor family, as a possible target for image-guided surgery of breast cancers. Two independent tissue micro arrays, consisting of matched sets of tumor and normal breast tissue, were stained for EphB4 by immunohistochemistry. The intensity of staining and the percentage of stained cells were scored by two independent investigators.
Immunohistochemical staining for EphB4 shows that breast cancer cells display enhanced membranous expression compared to adjacent normal breast tissue. The enhanced tumor staining is not associated with clinical variables like age of the patient or stage or subtype of the tumor, including Her2-status.
These data suggest that EphB4 is a promising candidate for targeted image-guided surgery of breast cancer, especially for Her2 negative cases.
靶向图像引导手术基于在给予放射性或荧光示踪剂后对肿瘤细胞的检测。因此,与健康组织相比,示踪剂与肿瘤组织的结合增强至关重要。各种肿瘤抗原已被评估为乳腺癌图像引导手术的可能靶点,但结果不一。
在本研究中,我们评估了酪氨酸激酶受体EphB4(Eph酪氨酸激酶受体家族的成员)作为乳腺癌图像引导手术的可能靶点。两个独立的组织微阵列,由匹配的肿瘤和正常乳腺组织组成,通过免疫组织化学对EphB4进行染色。两名独立的研究人员对染色强度和染色细胞百分比进行评分。
EphB4的免疫组织化学染色显示,与相邻的正常乳腺组织相比,乳腺癌细胞呈现增强的膜表达。肿瘤染色增强与患者年龄、肿瘤分期或亚型等临床变量无关,包括Her2状态。
这些数据表明,EphB4是乳腺癌靶向图像引导手术的一个有前景的候选靶点,尤其是对于Her2阴性病例。